Home › Lupus › District of Columbia › Washington
Lupus clinical trials in Washington, DC
10 studies for Lupus are looking for participants at sites in and around Washington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
- MedStar Georgetown University Hospital, Washington D.C.
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 mi away
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
RecruitingPhase 3
- Research Site, Washington D.C.
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires
RecruitingObservational study
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Bethesda · 7 mi away
A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
RecruitingPhase 3
- Research Site, Silver Spring · 7 mi away
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
RecruitingPhase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Study of Systemic Lupus Erythematosus
RecruitingObservational studyHealthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
RecruitingPhase 1/2Healthy volunteers welcome
- National Institutes of Health Clinical Center, Bethesda · 7 mi away
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
RecruitingObservational study
- Children's National Health System, Washington D.C.
Lupus Landmark Study: A Prospective Registry and Biorepository
RecruitingObservational study
- Georgetown University, Washington D.C.
Research Accelerated by You Lupus Registry
RecruitingObservational study
- Online Registry - No Physical Site Required, Washington D.C.
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Miami, FL11 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Santa Monica, CA8 studies
- Oklahoma City, OK8 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- Chicago, IL8 studies
Other studies in Washington
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer55 studies
- Breast Cancer46 studies
- Metastatic Cancer43 studies
- Lung Cancer41 studies
- Prostate Cancer38 studies
- Obesity33 studies
- Colorectal Cancer29 studies
- Cardiovascular Disease28 studies
- Bladder Cancer26 studies
- Acute Myeloid Leukemia24 studies
- Ovarian Cancer23 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.